Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

NYSE:DNA   3:59:56 PM EDT
2.96
+0.08 (+2.60%)
Other Pre-Announcement

Ginkgo Bioworks Reports Fourth Quarter Revenue Of $148 Mln

Published: 03/28/2022 20:15 GMT
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) - Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results.
Sees FY 2022 Revenue $325 Million to $340 Million.
Q4 2021 Total Revenue of $148 Million, Up From $32 Million.
Qtrly Loss per Share $1.10.
Q4 Earnings per Share View $-0.04, Revenue View $94.8 Million -- Refinitiv Ibes Data (analyst estimates).